- Trials with a EudraCT protocol (362)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
362 result(s) found for: Experimental Research.
Displaying page 1 of 19.
EudraCT Number: 2016-002663-33 | Sponsor Protocol Number: NUH-ALS-2015-04 | Start Date*: 2018-11-05 | |||||||||||
Sponsor Name:Alloksys Life Sciences BV | |||||||||||||
Full Title: Preventing Oxidative stress induced Ischemic Injury and Systemic Inflammation complications during and after invasive Cardiac surgery with Alkaline Phosphatase (APPIRED III) | |||||||||||||
Medical condition: systemic inflammation as side-effect of heart-lung machine during cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) NL (Ongoing) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003357-17 | Sponsor Protocol Number: Ketamin_SST01 | Start Date*: 2013-11-01 | ||||||||||||||||
Sponsor Name:Prof. Asbjørn Mohr Drewes | ||||||||||||||||||
Full Title: RESET Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of S-ketamine for pain treatment in chronic pancreatitis (RESET trial) | ||||||||||||||||||
Medical condition: Chronic Pancreatitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003728-39 | Sponsor Protocol Number: OTMother2014 | Start Date*: 2014-12-16 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Effects of maternal oxytocin on social information processing in mothers | ||
Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000746-32 | Sponsor Protocol Number: 5-HT_CFM | Start Date*: 2008-04-23 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Validation of experimental pain models as translational for craniofacial myalgia with respect to the influence of 5-HT, glutamate, cortisol and estradiol level | ||
Medical condition: Patients with craniomandibular myalgia (CM), i.e. with pain in the masster muscle and a diagnosis of myofascial pain according to the RDC/TMD criteria, and healthy subjects of both sexes, over 18 y... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002392-10 | Sponsor Protocol Number: S59302 | Start Date*: 2017-02-02 |
Sponsor Name:UZ Leuven | ||
Full Title: Reconsolidation interference versus retrieval interference as the basis for experimental amnesia in humans – The effect of drug state at memory retrieval | ||
Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test wether the internal drug ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004542-15 | Sponsor Protocol Number: SGN22E-003 | Start Date*: 2020-08-03 | |||||||||||||||||||||
Sponsor Name:Seattle Genetics, Inc. | |||||||||||||||||||||||
Full Title: An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab with or without chemotherapy, versus chemotherapy alone in previously untreated locally a... | |||||||||||||||||||||||
Medical condition: Urothelial cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Ongoing) NL (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) HU (Ongoing) DK (Trial now transitioned) IT (Restarted) PL (Trial now transitioned) CZ (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004169-34 | Sponsor Protocol Number: UoB1407 | Start Date*: 2012-02-07 |
Sponsor Name:University of Bristol | ||
Full Title: Effects of Varenicline and Cognitive Bias Modification on Neural Response to Smoking Cues | ||
Medical condition: Healthy volunteer trial: Neural responses to smoking cues Intended indication (Smoking cessation) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001976-39 | Sponsor Protocol Number: CHDR1227 | Start Date*: 2013-07-30 |
Sponsor Name:Centre for Human Drug Research | ||
Full Title: Randomized, open-label, crossover study into the contribution of the intestines and kidney in the diurnal variation of Levofloxacin pharmacokinetics | ||
Medical condition: The circadian variation in the relative contribution of intestinal uptake and renal elimination of levofloxacin | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001718-13 | Sponsor Protocol Number: MP18 | Start Date*: 2019-10-18 |
Sponsor Name:MAPS Europe B.V. | ||
Full Title: An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis... | ||
Medical condition: post-traumatic stress disorder (PTSD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) CZ (Completed) NO (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001626-22 | Sponsor Protocol Number: RML-TB | Start Date*: 2022-03-28 |
Sponsor Name:Vall d'Hebron Institute of Research | ||
Full Title: A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and safety profile of an anti-TB drug combination based on High Dose Rifampicin, High Dose Moxifloxacin and Linezoli... | ||
Medical condition: Smear-positive rifampicin-sensitive pulmonary Tuberculosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000810-12 | Sponsor Protocol Number: CO41101 | Start Date*: 2019-12-09 | ||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||
Full Title: A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF IPATASERTIB IN COMBINATION WITH ATEZOLIZUMAB AND PACLITAXEL AS A TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR META... | ||||||||||||||||||
Medical condition: Metastatic triple-negative breast cancer (TNBC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) FR (Completed) AT (Completed) PL (Completed) PT (Completed) IE (Prematurely Ended) ES (Completed) FI (Completed) HU (Ongoing) BE (Completed) GR (Prematurely Ended) BG (Completed) DK (Completed) RO (Ongoing) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003024-16 | Sponsor Protocol Number: ACT16482 | Start Date*: 2021-06-30 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Developpement | |||||||||||||
Full Title: Phase 1-2 UMBRELLA trial evaluating isatuximab with or without dexamethasone in combination with novel agents in relapsed or refractory multiple myeloma (RRMM) - Master protocol | |||||||||||||
Medical condition: Plasma cell myeloma refractory | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Prematurely Ended) FR (Ongoing) GR (Prematurely Ended) PT (Ongoing) DE (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000109-66 | Sponsor Protocol Number: TPU-TAS-102-301 | Start Date*: 2012-12-10 | |||||||||||
Sponsor Name:Taiho Oncology, Inc. | |||||||||||||
Full Title: RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAS-102 PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IN PATIENTS WITH METASTATIC COLORECTAL CANCER REFRACTORY TO STANDARD CHEMOTHERAPIES | |||||||||||||
Medical condition: Refractory metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) SE (Completed) AT (Completed) ES (Completed) IE (Completed) CZ (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000317-22 | Sponsor Protocol Number: BRE-ASA01 | Start Date*: 2017-04-13 |
Sponsor Name:Linköping University | ||
Full Title: A pilot study of low dose acetylsalicylic acid (ASA) for reduction of breast density and inflammation | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005431-13 | Sponsor Protocol Number: OTMother2015 | Start Date*: 2015-01-13 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Effects of maternal oxytocin on social information processing in mothers and infants | ||
Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18, Adults | Gender: Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001316-29 | Sponsor Protocol Number: 205801 | Start Date*: 2019-03-15 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd. | |||||||||||||
Full Title: A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in NSCLC Participants | |||||||||||||
Medical condition: non-small cell lung cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) DE (Ongoing) SE (Prematurely Ended) FR (Ongoing) DK (Prematurely Ended) IT (Ongoing) RO (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002706-36 | Sponsor Protocol Number: VASOPRESSOR-LPS | Start Date*: 2016-01-06 |
Sponsor Name:Radboudumc | ||
Full Title: The effects of different vasopressors on the innate immune response during experimental human endotoxemia, a pilot proof-of-principle study | ||
Medical condition: Possible future indications: infectious diseases which require vasopressor therapy. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000777-80 | Sponsor Protocol Number: SENS111-202 | Start Date*: 2018-06-08 |
Sponsor Name:Sensorion | ||
Full Title: A randomized, cross-over, placebo controlled, and meclizine calibrated study to assess the safety and pharmacodynamic effects of SENS-111 (100 mg and 200 mg) single dose in healthy subjects exposed... | ||
Medical condition: healthy volunteers (medicine for acute unilateral vertigo) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003238-35 | Sponsor Protocol Number: 4_141221 | Start Date*: 2021-09-15 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: Effects of supplemental oxygen on systemic and cerebral hemodynamics in experimental hypovolemia: A randomized, phase IV, crossover study to study the effect of supplemental oxygen vs. room air on ... | |||||||||||||
Medical condition: Hypovolemia is the condition under investigation. Hypovolemia is induced by the "lower body negative pressure" (LBNP)-model. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000649-30 | Sponsor Protocol Number: P150905 | Start Date*: 2016-09-29 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Impact of the administration of Fludrocortisone the fluid and electrolyte balance in great premature. Pilot study. | |||||||||||||
Medical condition: Great prematurity | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.